(Q41220119)

28 September 2017

1 reference

title

Immunopathogenesis of systemic sclerosis (English)

1 reference

28 September 2017

White B

1

1 reference

28 September 2017

1 November 1996

1 reference

Rheumatic Diseases Clinics of North America

28 September 2017

1 reference

28 September 2017

22

1 reference

28 September 2017

695-708

1 reference

28 September 2017

4

1 reference

Expression and Function of Surface Antigens on Scleroderma Fibroblasts

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Tumor necrosis factor-α (TNF-α), interferon-α (IFN-α) and interferon-γ (IFN-γ) receptors on human normal and scleroderma dermal fibroblasts in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Injection of anticentromere antibodies in interphase disrupts events required for chromosome movement at mitosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Interleukin-8 and neutrophils in systemic sclerosis with lung involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Cellular infiltrates in scleroderma skin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Analysis of the specificity of anti-PM-Scl autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Eosinophil activation in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Antimyenteric neuronal antibodies in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Identification of Fibroblasts Responsible for Increased Collagen Production in Localized Scleroderma by In Situ Hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Cytokine production and serum levels in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Increased interleukin 1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Decreased monocyte-mediated angiogenesis in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

B cell epitope on the U1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Autoantibody to centromere (kinetochore) in scleroderma sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Secretion and binding of transforming growth factor beta by scleroderma and normal dermal fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Sequential dermal microvascular and perivascular changes in the development of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

T cell receptor V beta repertoire of double-negative alpha/beta T cells in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Dermal mast cell degranulation in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Immunohistological demonstration of transforming growth factor-beta isoforms in the skin of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Studies on anti-granulocyte and anti-platelet antibodies in patients with systemic sclerosis. Chemotaxis, phagocytosis and opsonized effect of PSS sera on normal granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

An Fc gamma RIII (CD16)-specific autoantibody from a patient with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970296-9

7 January 2021

10.1016/S0889-857X(05)70296-9

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8923591